Genraule, Ariel S.
HRN: 28-86-06 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2026
CO-AMOXICLAV 625MG (TAB)
04/27/2026
05/04/2026
TAB
625mg
TID
Cap Mr
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines